Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein

Intern Med. 2013;52(10):1095-9. doi: 10.2169/internalmedicine.52.9477. Epub 2013 May 15.

Abstract

Myeloperoxidase- and proteinase 3-anti-neutrophil cytoplasmic antibodies (ANCAs) are often negative in cases in which systemic vasculitis is highly suspected. We herein present a case of bactericidal/permeability increasing protein (BPI)-ANCA-positive systemic vasculitis. This case highlights the possible role of BPI-ANCA in the pathogenesis of systemic vasculitis as well as the possible use of BPI as a diagnostic tool. The accumulation of further case-based reports is expected to shed some light on the pathogesis of systemic vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology*
  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Antibody Specificity
  • Antimicrobial Cationic Peptides / immunology*
  • Autoantigens / immunology*
  • Blood Proteins / immunology*
  • Bronchitis, Chronic / complications
  • Cyclophosphamide / therapeutic use
  • Diabetes Mellitus, Type 2 / complications
  • Female
  • Glomerulonephritis / etiology
  • Humans
  • Hyperlipidemias / complications
  • Immunosuppressive Agents
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / etiology
  • Pleural Effusion / etiology
  • Pneumoconiosis / complications
  • Prednisolone / therapeutic use
  • Radiography

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antimicrobial Cationic Peptides
  • Autoantigens
  • Blood Proteins
  • Immunosuppressive Agents
  • bactericidal permeability increasing protein
  • Cyclophosphamide
  • Prednisolone